Home LiteratureArticle Details
PMID: 9104802 Published · ppublish English Case Reports Journal Article Research Support, U.S. Gov't, P.H.S.

Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants.

The Journal of experimental medicine ·Vol. 185 ·No. 7 ·1997-04-07 ·Pages 1153-61

Pikora CA, Sullivan JL, Panicali D, Luzuriaga K

Abstract

High frequencies of cytotoxic T lymphocyte precursors (CTLp) recognizing HIV-1 laboratory strain gene products have been detected in adults within weeks of primary infection. In contrast, HIV-1-specific CTLp are uncommonly detected in infants younger than 6 mo. To address the hypothesis that the use of target cells expressing laboratory strain env gene products might limit the detection of HIV-1 env-specific CTLp in early infancy, recombinant vaccinia vectors (vv) expressing HIV-1 env genes from early isolates of four vertically infected infants were generated. The frequencies of CTLp recognizing target cells infected with vv-expressing env gene products from early isolates and HIV-1 IIIB were serially measured using limiting dilution followed by in vitro stimulation with mAb to CD3. In one infant, the detection of early isolate env-specific CTLp preceded the detection of IIIB-specific CTLp. CTLp recognizing HIV-1 IIIB and infant isolate env were detected by 6 mo of age in two infants. In a fourth infant, HIV-1 IIIB env and early isolate env-specific CTLp were simultaneously detected at 12 mo of age. These results provide evidence that young infants can generate HIV-1-specific CTL responses and provide support for the concept of neonatal vaccination to prevent HIV-1 transmission. However, the early predominance of type-specific CTL detected in some young infants suggests that the use of vaccines based on laboratory strains of HIV-1 may not protect against vertical infection.

MeSH Terms
Cloning, Molecular Cross Reactions Disease Progression Gene Products, env/genetics,immunology Genes, env HIV Infections/immunology,transmission HIV-1/immunology Hematopoietic Stem Cells/immunology Humans Infant Infant, Newborn Infectious Disease Transmission, Vertical Polymerase Chain Reaction T-Lymphocytes, Cytotoxic/immunology Time Factors
Chemicals
Gene Products, env
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Pikora C A
Department of Pediatrics, University of Massachusetts Medical Center, Worcester 01605, USA.
Sullivan J L
Panicali D
Luzuriaga K
References (23)
23 references, click to expand
  1. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.
    Scand J Clin Lab Invest Suppl. 1968;97:77-89 PMID: 4179068
  2. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity.
    J Exp Med. 1995 Feb 1;181(2):453-61 PMID: 7530756
  3. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins.
    J Virol. 1989 May;63(5):2270-7 PMID: 2522999
  4. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations.
    Cell. 1989 Sep 8;58(5):901-10 PMID: 2550139
  5. Selective reduction and proliferation of the CD4+ and CD8+ T cell subsets with bispecific monoclonal antibodies: evidence for inter-T cell-mediated cytolysis.
    Clin Immunol Immunopathol. 1991 Feb;58(2):236-50 PMID: 1824687
  6. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities.
    J Exp Med. 1991 Dec 1;174(6):1593-600 PMID: 1744586
  7. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro.
    J Virol. 1992 Feb;66(2):875-85 PMID: 1731112
  8. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants.
    Science. 1992 Feb 28;255(5048):1134-7 PMID: 1546316
  9. Proposed definitions for in utero versus intrapartum transmission of HIV-1.
    N Engl J Med. 1992 Oct 22;327(17):1246-7 PMID: 1406816
  10. Report of a Consensus Workshop, Siena, Italy, January 17-18, 1992. Maternal factors involved in mother-to-child transmission of HIV-1.
    J Acquir Immune Defic Syndr. 1992 Oct;5(10):1019-29 PMID: 1453317
  11. Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers.
    Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1721-5 PMID: 8446584
  12. Generation and analysis of vaccinia virus recombinants.
    Methods Enzymol. 1993;217:557-81 PMID: 8474351
  13. Genotypic and phenotypic characterization of HIV-1 patients with primary infection.
    Science. 1993 Aug 27;261(5125):1179-81 PMID: 8356453
  14. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes.
    Science. 1993 Nov 19;262(5137):1257-61 PMID: 8235655
  15. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    J Exp Med. 1994 Jun 1;179(6):1933-43 PMID: 8195718
  16. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
    J Virol. 1994 Jul;68(7):4650-5 PMID: 8207839
  17. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
    J Virol. 1994 Sep;68(9):6103-10 PMID: 8057491
  18. High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection.
    J Infect Dis. 1994 Oct;170(4):766-74 PMID: 7930716
  19. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    N Engl J Med. 1994 Nov 3;331(18):1173-80 PMID: 7935654
  20. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life.
    J Immunol. 1995 Jan 1;154(1):433-43 PMID: 7995957
  21. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.
    Science. 1995 Jan 27;267(5197):483-9 PMID: 7824947
  22. The global HIV pandemic.
    Acta Paediatr Suppl. 1994 Aug;400:1-4 PMID: 7833548
  23. The evaluation of limiting dilution assays.
    J Immunol Methods. 1982 Mar 12;49(2):R11-23 PMID: 7040548
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1997-04-07
Pages
1153-61
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2196268
Subset
IM
Grants
NIAID NIH HHS · AI-32391 · United States
NIAID NIH HHS · AI-26507 · United States
NIAID NIH HHS · AI-32907 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com